Latest filing published 09 Feb 2022 for Aerie Pharmaceuticals INC, €7,117.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Thomas A. Mitro: trading record in brief
This profile gathers the share dealings of Thomas A. Mitro across 2 companies, led by Ista Pharmaceuticals Inc and Aerie Pharmaceuticals Inc. Between 16 February 2006 and 8 February 2022, the trades on record add up to 80 filings.
Both buying and selling appear: 5 purchases worth €65k, against 2 sales worth €9.8M. Sales outweigh purchases by €9.7M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 52 share grants and 10 option exercises.
The median purchase comes to €6,485.
Most recently, on 9 February 2022, the filings show a share grant worth €7,117 in Aerie Pharmaceuticals Inc. The latest purchase dates back some time: it was published 4,755 days ago, on 1 November 2013. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Thomas A. Mitro
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,111 shares@ US$7.330.1% of flowCommon StockSEC:0001209191-22-008227:1
- 1,310 shares@ US$7.2448.3% of flowCommon StockSEC:0001209191-22-008227:0
- 1,435 shares@ US$7.050.1% of flowCommon StockSEC:0001209191-22-007893:1
- 1,435 shares@ US$7.0551.7% of flowCommon StockSEC:0001209191-22-007893:0
- 763 shares@ US$15.660.1% of flowCommon StockSEC:0001209191-21-014445:0
- 1,438 shares@ US$17.680.2% of flowCommon StockSEC:0001209191-21-009019:0
- 1,229 shares@ US$17.680.2% of flowCommon StockSEC:0001209191-21-009019:1
- 1,085 shares@ US$17.720.1% of flowCommon StockSEC:0001209191-21-009019:2
- 14,000 shares0Common StockSEC:0001209191-21-008583:0
- 2,345 shares@ US$14.8524.7% of flowCommon StockSEC:0001209191-20-030125:0
- 763 shares@ US$21.5911.7% of flowCommon StockSEC:0001209191-20-012530:0
- 1,027 shares@ US$20.3014.8% of flowCommon StockSEC:0001209191-20-012530:1
- 1,307 shares@ US$20.4918.7% of flowCommon StockSEC:0001209191-20-008486:0
- 1,183 shares@ US$20.4916.9% of flowCommon StockSEC:0001209191-20-008486:1
- 14,000 shares0Common StockSEC:0001209191-20-008051:0
- 13,559 shares0Common StockSEC:0001209191-19-031043:0
- 2,345 shares@ US$40.540.8% of flowCommon StockSEC:0001209191-19-031043:1
- 1,564 shares@ US$41.890.5% of flowCommon StockSEC:0001209191-19-024575:0
- 763 shares@ US$40.040.2% of flowCommon StockSEC:0001209191-19-013744:0
- 1,027 shares@ US$40.040.3% of flowCommon StockSEC:0001209191-19-013744:1
- 1,027 shares@ US$40.180.3% of flowCommon StockSEC:0001209191-19-013744:2
- 1,241 shares@ US$40.390.4% of flowCommon StockSEC:0001209191-19-009018:1
- 12,778 shares0Common StockSEC:0001209191-19-009018:0
- 182,668 shares@ US$3.154.5% of flowCommon StockSEC:0001209191-18-048785:0
- 7,332 shares@ US$3.150.2% of flowCommon StockSEC:0001209191-18-048785:1
25 of 79 declarations
